Published on : Apr 18, 2016
ALBANY, New York, April 18, 2016: Immunotherapy refers to a treatment consisting of enhancing or further suppressing the innate powers of the immune system of the patient. The properties of the immune system to fight against intrusions help immunotherapy drugs in fighting with several diseases including respiratory, cancer, infectious, and autoimmune disorders. According to the research study, the global market for immunotherapy drugs is projected to exhibit a healthy 11.52% CAGR between 2016 and 2020.
The growing prevalence of autoimmune diseases and cancer is one of the major factors driving the global market for immunotherapy drugs. In addition, the growing geriatric population worldwide, increasing patent assistance programs, increase in demand for mAbs, and promising pipeline are some of the other factors that are expected to augment the growth of the market throughout the forecast period. Moreover, the increasing number of awareness programs, emergence of biosimilars, introduction of targeted and combination therapies, strategic alliances, and expected entry of novel vaccines are some of the current market trends that are anticipated to boost the demand for immunotherapy drugs in the next few years.
Click here to get more info with TOC in a PDF Format: http://www.researchmoz.us/enquiry.php?type=S&repid=685210
On the flip side, high costs of biologicals, patent expiry of top-selling drugs, stringent regulations, and poor diagnosis and screening procedures are some of the key factors that are hampering the growth of the global market for immunotherapy drugs. Apart from this, the adverse effects of drugs on some patients is another factor expected to curb the growth of the market in the near future.
The global market for immunotherapy drugs has been divided on the basis of type of immunotherapy into vaccines, immune checkpoint inhibitors, mAbs, and non-specific immunotherapies. Furthermore, on the basis of geography, the global market for immunotherapy drugs has been classified into the Americas, EMEA, and APAC. The research report has further provided market shares, historical data, revenue generation opportunities, and forecast statistics of each segment.
The research study has further covered the competitive landscape and vendor analysis of the global market for immunotherapy drugs, including detailed profiles of the major players operating in the market. The prominent players in the immunotherapy drugs market include Amgen Inc., AbbVie Inc., Johnson & Johnson Private Ltd., Bristol-Myers Squibb Company (BMS), Merck & Co. Inc., and F. Hoffmann-La Roche AG. Some of the other key vendors mentioned in the research report are Cytos Biotechnology, AstraZeneca, Genexine, Coherus BioSciences, Pfizer, Cel-Sci, KaloBios Pharmaceuticals, and Novo Nordisk.
To order report Call USA – Canada Toll Free: 866-997-4948 or send an email on email@example.com